tbuckley/cabot-search huggingface dataset:
Response, Peak and Persistence of Varnimcabtagene Autoleucel (IMN-003A), First-in-India Industry CD19-Directed CAR-T Cell Therapy, with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies: Early Results (IMAGINE Study)
Authors: Sunil Bhat, Sharat Damodar, Pooja Mallya, Akshatha Nayak, Ravi Joshi, Bharath Ram S, Sudarshan Chougule, Deepak MB, Gopinadh Jakka, Sudeshna Dhar, Anne Roshan Joseph, Arun Kumar MG, Murugan Palanisamy, Jeetendra Kumar, Melina Soares, Pallavi Arasu, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Anil Kamat
Journal: Blood (2022)
Outcomes of Cold-Stored, Low Titer Group O Whole Blood Transfusions in Non-Trauma Massive Transfusion Protocol Activations in Patients with Cirrhosis
Authors: Simone E. Dekker, Jacqueline Chang, Carley Little, Rafael Ornelas, Janice Jou, Trisha E. Wong, Martin Schreiber, Joseph J Shatzel
Journal: Blood (2022)
Comparison of Chronic Health Conditions and Health Behaviors in Long-Term Young Adult Hodgkin Lymphoma (YAHL) Survivors to That of Their Unaffected Co-Twin Controls
Authors: Marcie Haydon, Amie E. Hwang, Esther Lam, Laura Buchanan, Marta Epeldegui, Joel Milam, Thomas M. Mack, David V Conti, John Hopper, Wendy Cozen
Journal: Blood (2022)
Fixed Duration Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone Quadruplet for Newly Diagnosed Multiple Myeloma - MRD Negativity and Survival Outcomes
Authors: Shaji K Kumar, Betsy Laplant, Erik J Asmus, Francis K. Buadi, Wilson I. Gonsalves, Eli Muchtar, David Dingli, Melanie Ann Thompson, Ronald Go, Rahma M Warsame, Taxiarchis Kourelis, Yi L. Hwa, Amie Fonder, Miriam A. Hobbs, Martha Q. Lacy, Angela Dispenzieri, Suzanne R. Hayman, Nelson Leung, Moritz Binder, S. Vincent Rajkumar, Morie A Gertz, Prashant Kapoor
Journal: Blood (2022)
Outcomes Analysis of T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (T-ALL/T-LBL) in a Minority Rich Cohort
Authors: Karun Neupane, Abdul-Hamid Bazarbachi, Daniel K. Reef, Kith Pradhan, Hiba Narvel, Alyssa De Castro, Felisha Joseph, Kailyn Gillick, Fariha Khatun, Amanda Lombardo, Yang Shi, Yanhua Wang, Kira Gritsman, Ulrich Steidl, Mendel Goldfinger, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier Rodriguez, Nishi Shah, Dennis Cooper, Ira Braunschweig, Amit Verma, Bin Hilda Ye, Marina Konopleva, R. Alejandro Sica
Journal: Blood (2022)
<i>Obstacles in Diagnosing and Treating a Case of Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma; A Case Report</i>
Authors: Emad Azmy, Esraa Jamal, Elbeah Z.M, Raghda Ibrahim F. Khalifa, Noreen M.A El-bayoumi, Hasan A. Abdel-ghaffar
Journal: Blood (2022)
Impaired Clearance of <i>DNMT3A/TET2/ASXL1</i>-Mutant Clones with Hypomethylating Agent or Intensive Induction Chemotherapy for Myelodysplastic Syndrome and Acute Myeloid Leukemia
Authors: Shyam A Patel, William K Gerber, Lloyd Hutchinson, Jan Cerny, Muthalagu Ramanathan, Andrew Gillis-Smith, Sakiko Suzuki, Salwa Khedr, Bruce Woda, William Selove, Jonathan M Gerber
Journal: Blood (2022)
Loss of DHX15 Function Impairs Hematopoiesis in Vav-Dhx15-KO Mice and Cause DNA Damage-Induced Cell Cycle Arrest and Apoptosis in Leukemia Cell Lines
Authors: Xuechun Wang, Luya Ye, Yuanhua Cai, Qiao Liu, Zhixiang Chen, Fuquan Tu, Xiaolin Lai, Lili Pan, Yang Li, Xiaofan Li, Shaoyuan Wang
Journal: Blood (2022)
Comparing Outcomes of Outpatient Vs. Inpatient High-Dose Melphalan Based Conditioning Regimens Followed By Autologous Hematopoietic Cell Transplantation in Myeloma
Authors: Taiga Nishihori, Doris K. Hansen, Hien D. Liu, Omar Alexis Castaneda Puglianini, Ciara L. Freeman, Brandon J. Blue, Jason Brayer, Jongphil Kim, Ariel F Grajales-Cruz, Jose Ochoa, Rachid C. Baz, Kenneth H. Shain, Frederick L. Locke, Melissa Alsina
Journal: Blood (2022)
Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma
Authors: Julius Christoph Enssle, Alina Moter, Julia Campe, Alec Gessner, Ika Weijia Yu, Sebastian Wolf, Björn Steffen, Hubert Serve, Melanie Bremm, Sabine Huenecke, Michael Lohoff, Maria Vehreschild, Holger F. Rabenau, Marek Widera, Sandra Ciesek, Michael A Rieger, Katharina Imkeller, Ivana von Metzler, Evelyn Ullrich
Journal: Blood (2022)
Fitusiran Reaches People's with Hemophilia and Their Caregivers’ Treatment Expectations: Qualitative Semi-Structured Interviews of Participants of ATLAS-OLE Trial (Interim analysis)
Authors: Alok Srivastava, Savita Rangarajan, Cecil Ross, Christina Slota, Dana DiBenedetti, Viridiana Cano, Shauna Andersson, Pronabesh Dasmahapatra, José Bartelt-Hofer, Marion Afonso
Journal: Blood (2022)
Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in NPM1-Mutated Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
Authors: Ali Hussain, Moazzam Shahzad, Sakina Abbas, Junaid Khan, Ali Hassan Mushtaq, Muhammad Fareed Khalid, Murali Krishna Gurram, Iqra Anwar, Sibgha Gull Chaudhary, Peiman Hematti, Sunil H Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2022)
Epidemiological Impact of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone (Pola-R-CHP) Use in Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) in Terms of Second Line (2L) Treatment: An Ad Hoc Analysis from the POLARIX Study
Authors: Frédéric Boissard, Hervé Tilly, Georg Lenz, Graham P. Collins, Antonio Pinto, Laurie H. Sehn, Gilles Salles, Mathilde Roussel, Leonardo Simonella, Rodrigo Ho, Jamie Hirata, Calvin Lee, Anthony Masaquel, Aino Launonen
Journal: Blood (2022)
Interim Results of a Prospective Trial Testing Vaccination Against Pneumococcus before and after CD19 CAR T Cell Therapy to Optimize Humoral Immunity
Authors: Dasom Lee, Abida Poovathukaran Babu, Salvatore A. Corallo, Meghan A. Menges, Melanie J. Hidalgo-Vargas, Danielle M. Ames, Aleksandr Lazaryan, Taiga Nishihori, Farhad Khimani, Sameh Gaballa, Bijal D. Shah, Javier Pinilla Ibarz, Julio C. Chavez, Michael D. Jain, Frederick L. Locke
Journal: Blood (2022)
Mitochondrial Regulation of Ferroptosis in Acute Myeloid Leukemia
Authors: Hiroki Akiyama, Ran Zhao, Yuki Nishida, Natalia Baran, Ziyi Li, Lauren B Ostermann, Po Yee Mak, Edward Ayoub, Sujan Piya, Bing Z Carter, Michael Andreeff, Jo Ishizawa
Journal: Blood (2022)
Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients with Relapsed or Refractory T-Cell Lymphoma (TCL) with Survival Analysis
Authors: Owhofasa O. Agbedia, Rishab Prakash, Jie Xu, Melody R. Becnel, Ranjit Nair, Raphael E Steiner, Lei Feng, Hun Ju Lee, Paolo Strati, Sairah Ahmed, Simrit Parmar, Yago Nieto, Chitra Hosing, Jason Westin, Loretta J. Nastoupil, Ann Vo, Felipe Samaniego, Nathan H. Fowler, Neeraj Saini, Issa F. Khouri, Jin S. Im, Luis Fayad, Preetesh Jain, Michael L. Wang, Roberto N. Miranda, Francisco Vega, Jeffrey Medeiros, Yasuhiro Oki, Christopher R. Flowers, Sattva S. Neelapu, Swaminathan P. Iyer
Journal: Blood (2022)
Efficacy and Safety of Tranexamic Acid for Reduction in Blood Transfusions in Patients Undergoing Major Non-Cardiac Surgeries: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Authors: Maurish Fatima, Aleena Ahmed, Zaofashan Zaheer, Ahmad Zain, Masood Azhar, Muhammad Ahsan Hanif Chaudhary, Muhammad Wahaj Murad, Muhammad Huzaifa Ahmed Khan, Usman Ali Akbar, Mohammad Ebad Ur Rehman, Faiz Anwer
Journal: Blood (2022)
Patients Outcome after Chimeric Antigen Receptor (CAR) T-Cells Failure in Aggressive B-Cell Lymphomas: Role of Immunotherapy and Prognostic Factors
Authors: Anna Dodero, Stefania Bramanti, Martina Pennisi, Silva Ljevar, Annalisa Chiappella, Massimo Magagnoli, Anna Guidetti, Francesco Corrado, Paulina Nierychlewska, Alice Di Rocco, Antonello Domenico Cabras, Daoud Rahal, Chiara De Philippis, Armando Santoro, Carmelo Carlo-Stella, Paolo Corradini
Journal: Blood (2022)
LSC17 Score Is Complementary with Minimal Residual Disease to Stratify <i>NPM1</i>-Mutated Acute Myeloid Leukemia: An ALFA Study
Authors: Loïc Vasseur, Laurène Fenwarth, Xavier Thomas, Jérôme Lambert, Stéphane de Botton, Martin Figeac, Céline Villenet, Pierre-Yves Dumas, Christian Recher, Céline Berthon, Emilie Lemasle, Delphine Lebon, Juliette Lambert, Christine Terré, Karine Celli-Lebras, Hervé Dombret, Claude Preudhomme, Meyling Cheok, Raphael Itzykson, Nicolas Duployez
Journal: Blood (2022)
Clonal Hematopoiesis in Mice Is Common with Age and Accelerated By Microbial Exposure
Authors: Chiraag D. Kapadia, Matthew Yousefzadeh, Emily Mitchell, Duy Le, Nicholas Williams, Marcus A. Florez, Katherine Y. King, Laura Niedernhofer, Jyoti Nangalia, Margaret A. Goodell
Journal: Blood (2022)
Emapalumab for Malignancy-Associated Hemophagocytic Lymphohistiocytosis: The Memorial Sloan Kettering Cancer Center Experience
Authors: William T. Johnson, Zachary D. Epstein-Peterson, Nivetha Ganesan, Tiffany Chang, Natasha Galasso, Robert Stuver, Niloufer Khan, Gilles Salles, Alison J. Moskowitz, Santosha Vardhana, Steven M. Horwitz
Journal: Blood (2022)
Survival Prediction Optimization of Acute Myeloid Leukemia Based on T-Cell Function-Related Genes and Plasma Proteins
Authors: Shuzhao Chen, Yun Wang, Peidong Chi, Runcong Nie, Robert Peter Gale, Hanying Huang, Zhigang Chen, Yanyu Cai, Enping Yan, Na Zhong, Xinmei Zhang, Yang Liang
Journal: Blood (2022)
Single-Cell Profiling of CD8 Landscape in Treatment Naïve and Relapsed/Refractory AML Patients Reveals Distinct Effector Cellular States Predictive of Outcomes
Authors: Poonam Desai, Bofei Wang, Fatima Zahra Jelloul, Gheath Alatrash, Natalia Baran, Qing Deng, Michael R Green, Naval Daver, Marina Konopleva, Andy Futreal, Dapeng Hao, Hussein A Abbas
Journal: Blood (2022)
Allogeneic Donor T Cells Directly Attack Renal Endothelial and Epithelial Cells in Mice
Authors: Masahiro Miyata, Eri Matsuki, Yuka Hosokawa, Masahiro Suto, Kazunobu Ichikawa, Dan Peltier, Kenichi Ishizawa, Masafumi Watanabe, Tomomi Toubai
Journal: Blood (2022)
ITCC-101/APAL2020D: A Randomized Phase 3 Trial of Fludarabine/Cytarabine/Gemtuzumab Ozogamycin with or without Venetoclax in Children with Relapsed Acute Myeloid Leukemia
Authors: Sae Ishimaru, Gwenaëlle Gueguen, Seth E. Karol, Francisco J. Bautista Sirvent, Valeria Ceolin, Bianca F. Goemans, Marlous Bakker, Laura Di Laurenzio, Jennifer Lukin, Harm Van Tinteren, Gauri B. Sunkersett, Maika Onishi, Kristina Unnebrink, Dirk Reinhardt, Gwen L Nichols, E. Anders Kolb, C. Michel Zwaan
Journal: Blood (2022)
Inpatient Burden and Clinical Outcomes of Febrile Neutropenia in Cancer Patients: A National Inpatient Sample Database Analysis
Authors: Sarah S. Makhani, Calvin Abro, Sujitha Ketineni, Xianming Zhu, Vivek Prakash, Ishan Agarwal, Mohammed Hussain, Evan Bloch, Cassandra D. Josephson, Aaron Tobian, Ruchika Goel
Journal: Blood (2022)
Real World Effectiveness of "7 + 3" Intensive Chemotherapy Vs Venetoclax and Hypomethylating Agent for Initial Therapy in Adult Acute Myeloid Leukemia
Authors: Andrew Matthews, Alexander E. Perl, Selina M. Luger, Saar Gill, Catherine Lai, David L. Porter, Sarah Skuli, Ximena Jordan Bruno, Craig W. Freyer, Alison Carulli, Martin P. Carroll, Daria V. Babushok, Noelle V. Frey, Elizabeth O. Hexner, Mary Ellen Martin, Shannon R. McCurdy, Edward A. Stadtmauer, Alison W. Loren, Vikram R Paralkar, Ivan Maillard, Keith W. Pratz
Journal: Blood (2022)
Real-World Evidence of Collecting Quality of Life (QoL) and Symptoms Perception Using the HM-PRO© Tool As a Patient-Reported Outcome Measure (PROM) in Patients with Lymphoma While Receiving Intravenous Chemotherapy
Authors: Lucía Castilla García, Sergio Ramos Cillán, Alberto Lopez García, Natalia Barreras Ruiz, Eva Castillo Bazan, Adriana Pascual, Miriam Riesco Ovelar, Celia Urrutia, Susana Cruz, Alberto Pardo, Antonio Herrero, Maria Angeles Perez Saenz, Daniel Morillo Gilles, María Pilar Llamas Sillero, Javier Becares, Carla Barriocanal, Jorge Short Apellaniz, Marta del Olmo, Javier Arcos Campillo, Raul Cordoba
Journal: Blood (2022)
Assessing the Recovery Process after a Vaso Occlusive Crisis
Authors: Maya Holmes, Manuela Plazas Montana, Daniel Semakula, Apoorva Ojha, Blair Chang, Jaanvi Mahesh, Jayla Lynn Scott, Wingel Xue, Shubhangy Raghavan, Ronda Wright, Jessica Liang, Sophie M. Lanzkron
Journal: Blood (2022)
Drug Interaction Potential As a Result of Cytokine Release Syndrome Using a Physiologically Based Pharmacokinetic Model: Case Study of Teclistamab
Authors: Marie-Emilie Willemin, Shun Xin Wang Lin, Loeckie De Zwart, Liviawati S. Wu, Xin Miao, Raluca Verona, Arnob Banerjee, Baolian Liu, Rachel Kobos, Ming Qi, Daniele Ouellet, Jenna D. Goldberg, Suzette Girgis
Journal: Blood (2022)
Belantamab Mafodotin in Combination with Pomalidomide and Dexamethasone Demonstrates Durable Responses in Triple Class Exposed/Refractory Multiple Myeloma
Authors: Suzanne Trudel, Arleigh McCurdy, Molei Fu, Heather J. Sutherland, Martha L Louzada, Michael P. Chu, Darrell J White, Hira S Mian, Rami Kotb, Ibraheem Othman, Moustafa Kardjadj, Engin Gul, Donna E. Reece
Journal: Blood (2022)
Disrupted Lipid Homeostasis and Loss of IRF4 Impairs B-Cell and Plasma Cell Development in a Murine Model of Accelerated Aging
Authors: Silvia Vicenzi, Lara Avsharian, Fangyuan Gao, Qianlan Xu, Kseniya Malukhina, Dorota Skowronska-Krawczyk, Leslie Crews
Journal: Blood (2022)
Time to Event Surrogate Endpoints in Multiple Myeloma Randomized Trials from 2005-2019: A Surrogacy Analysis
Authors: Tommy Etekal, Kelly Koehn, Douglas W. Sborov, Brian McClune, Vinay Prasad, Alyson Haslam, Katherine Berger, Christopher Booth, Samer Al Hadidi, Al-Ola Abdallah, Aaron M. Goodman, Ghulam Rehman Mohyuddin
Journal: Blood (2022)
Safety and Anti-Leukemic Activity of CD123-CAR T Cells in Pediatric Patients with AML: Preliminary Results from a Phase 1 Trial
Authors: Swati Naik, Renee M. Madden, Amanda Lipsitt, Timothy Lockey, Jennyfer Bran, Jeffrey E. Rubnitz, Jeffery Klco, Barry Shulkin, Sagar L. Patil, Sarah Schell, Jeoungeun John Park, Janice Riberdy, Na Shang, Jaquelyn T. Zoine, Jennifer Wallace, Elaine Harstead, Catherine Willis, Jean-Yves Metais, Deanna M. Langfitt, Sheng Zhou, Salem M. Akel, Michael M. Meagher, Brandon M. Triplett, Stephen Gottschalk, Mireya Paulina Velasquez
Journal: Blood (2022)
Special Anatomical Subtypes of Diffuse Large B-Cell Lymphoma Have Distinct Tumor Microenvironments
Authors: Troy Noordenbos, Fleur A De Groot, Ruben A.L. De Groen, Lorraine M. De Haan, Ricki T. Krog, Aniko Sijs-Szabo, Marieke Griffioen, Rosa de Groot, Mirjam H.M. Heemskerk, Marieke E. Ijsselsteijn, Valeska Terpstra, Marcel Nijland, Pim Mutseaers, Martine E.D. Chamuleau, Marie Jose Kersten, Arjan Diepstra, Judith Bovée, Patty M. Jansen, Noel F.C.C. De Miranda, Joost S.P. Vermaat
Journal: Blood (2022)
Combination Therapy to Enable AAV Re-Dosing and Mitigate Transgene Immunity in Liver-Targeted Gene Therapy
Authors: Jyoti Rana, Sandeep RP Kumar, Maite Munoz, Kentaro Yamada, Thais Bertollini, David M Markusic, Manuela Corti, Barry J Byrne, Roland W Herzog, Moanaro Biswas
Journal: Blood (2022)
Autologous Stem Cell Transplantation for Treatment with Curative Intent in Adult Patients with Acute Lymphoblastic Lymphoma
Authors: Jessica L. Bazin, Yasser Abou Mourad, Donna L. Forrest, Kevin Hay, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Maryse Power, Judith A Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J. Stubbins, Heather J. Sutherland, Cynthia L. Toze, Jennifer White, Shanee Chung
Journal: Blood (2022)
Rituximab Maintenance (RM) after First-Line (1L) Treatment Is Associated with a Lower Risk of Early-POD in Patients with Mantle Cell Lymphoma (MCL)
Authors: Alba Cabirta, Pau Abrisqueta, Víctor Navarro Garcés, Marta Canelo-Vilaseca, Marina Gomez-Rosa, Alberto Lopez García, Tomas García, Fatima De la Cruz, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Moraima Jiménez, Sabela Bobillo, Marta Julia, Cecilia Carpio, Gloria Iacoboni, Laura Gallur, Josep Castellvi, Francesc Bosch, Ana Marin-Niebla
Journal: Blood (2022)
Treatment-Free Remission Outcome in Patients with Chronic Myeloid Leukemia in Chronic Phase Following One Year of Nilotinib De-Escalation: 96-Week Update of Dante Study
Authors: Fabio Stagno, Elisabetta Abruzzese, Alessandra Iurlo, Fabrizio Pane, Imma Attolico, Paolo Sportoletti, Patrizia Pregno, Sara Galimberti, Barbara Scappini, Maurizio Miglino, Sergio Siragusa, Isabella Capodanno, Diletta Valsecchi, Aurelio Pio Nardozza, Paola Coco, Gianantonio Rosti, Giuseppe Saglio, Massimo Breccia
Journal: Blood (2022)
Breadth of the Human Leukocyte Antigens Class I Immunopeptidome in Allogenic Hematopoietic Stem Cell Transplantation Outcomes for Myeloid Malignancy
Authors: Kyoko Fuse, Tatsuya Suwabe, Takayuki Katagiri, Yasuhiko Shibasaki, Hirohito Sone, Masayoshi Masuko
Journal: Blood (2022)
Multicenter Phase I Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia
Authors: Leland Metheny, Ronald M. Sobecks, Christina Cho, Jiasheng Wang, Lisa Ciarrone, Paolo F. Caimi, Folashade Otegbeye, Brenda W. Cooper, Molly Gallogly, Ehsan Malek, Aaron T. Gerds, Betty K. Hamilton, Sergio A Giralt, Miguel-Angel Perales, Marcos J.G. de Lima
Journal: Blood (2022)
The Role of Relapse Specific over-Expression of S100A8/A9 B Leukemic Cells in Promoting Chemoresistance
Authors: Clemence Aldebert, Emily Duan, Sylwia Jasinski, Talia H Ostrow, Isaiah Gonzalez, Aristotelis Tsirigos, Elizabeth A. Raetz, Nikki Ann Evensen, William L. Carroll
Journal: Blood (2022)
Optimizing the Frequency of Transcranial Doppler (TCD) Exams in Children with Sickle Cell Anemia
Authors: Ayobami Olanrewaju, Zachary Abramson, Jane S Hankins, Clifford Takemoto, M. Beth McCarville, Andrew M Heitzer, Guolian Kang, Victoria Okhomina, Winfred C. Wang
Journal: Blood (2022)
A Phase II Multicenter Clinical Trial Assessing the Safety and Efficacy of Ixazomib Pomalidomide Dexamethasone Combination As Second or Third-Line Treatment for Patients with Triple Exposed Relapsed and Refractory Multiple Myeloma: Prespecified Interim Analysis (IPoD-790 trial)
Authors: Yael C Cohen, Tamir Shragai, Noa Lavi, Iuliana Vaxman, Evgeni Chubar, Moshe E Gatt, Chezi Ganzel, Hila Magen, Efrat Luttwak, Noa Lowenton-Spier, Liron Gez-Aaronson, Natan Melamed, Irit Avivi
Journal: Blood (2022)
Trial in Progress: AB-101, an Allogeneic, Non-Engineered, Cord Blood-Derived Natural Killer (NK) Cell Therapy, As Monotherapy or in Combination with Rituximab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
Authors: Rashmi Khanal, Jennifer N. Saultz, Umar Farooq, Sunita Nathan, Amitkumar Mehta, Ayad Hamdan, Lawrence E. Morris, Houston Holmes, Lauren C. Pinter-Brown, John K.C. Lim, Amanda Conerty, Heather Raymon, Peter Flynn, Anita G. Seto, Joseph J. Maly
Journal: Blood (2022)
Functional Role of Histone Variant macroH2A1 (H2AFY) in Acute Myeloid Leukemia (AML)
Authors: Chen-Jen Hsu, Tina M. M Schnoeder, Theresa Eifert, Qirui Zhang, Oliver Meers, David Corujo, Maximilian Lassi, Raffaele Teperino, Stefan Dimitrov, Holger Bierhoff, Björn von Eyss, Florian Perner, Marcus Buschbeck, Florian H. Heidel
Journal: Blood (2022)
NOTCH1 Signaling Is Dysregulated in CLL By the Deubiquitinase USP28 That Is Recurrently Affected By Del(11q) and Can be Therapeutically Targeted
Authors: Alena Sophie Ehrmann, Miguel Quijada Álamo, Viola Close, Min Guo, Claudia Pérez Carretero, Luis A Corchete, Eugen Tausch, Christof Schneider, Hartmut Döhner, Stephan Stilgenbauer, Franz Oswald, Jesus Maria Hernández-Rivas, Daniel Mertens
Journal: Blood (2022)
The Effects of Immunomodulation with Corticosteroids to Manage an AAV Capsid Immune response in the Phase I/II Study of SPK-8011
Authors: Matthew S. Evans, Witold B. Rybka, Stacy E. Croteau, Huyen Tran, John E.J. Rasko, Kristen Jaworski, Amy MacDougall, Savina Jaeger, Federico Mingozzi, Tiffany Chang, Gallia Levy
Journal: Blood (2022)
ERK1/2 Inhibition Overcomes Resistance to Venetoclax in AML By Altering Drp1-Dependent Mitochondrial Fission and Metabolism
Authors: Priyanka Sharma, Sujan Piya, Natalia Baran, Anna Zal, Christopher J. Hindley, Kim-Hien Dao, Martin Sims, Tomasz Zal, Vivian Ruvolo, Michael Andreeff, Gautam Borthakur
Journal: Blood (2022)
MAC Plus Study: A Retrospective Study Correlating DNA Variants, Clinical Course and Outcomes from 187 Patients Who Underwent Testing Using an Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathy Genetic Sequencing Panel
Authors: Jihyun Moon, Jamey Kain, Fernando C. Fervenza, Stephen B Erickson, Prince Singh, Shahrzad Tehranian, Craig B. Langman, Ramy Hanna, Paul Brakeman, Christopher C. Dvorak, Shaun David Lawicki, Amita Sharma, Jooeun Lim, Sujatha Venkataramani, Mike Ero, Bradley Lewis
Journal: Blood (2022)
Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study
Authors: Aamer Aleem, Farjah Alqahtani, Ahmed Jamal, Nora A. Alkhudair, Mashail Alghafis, Hajar Wan Zuki Siti, Bader Alahmari, Hend Salama, Giamal Edin Gmati, Mohsen Alzahrani, Ayman Alhejazi, Naila A. Shaheen, Abdullah M Alrajhi, Mansour Alfayez, Zafar Iqbal, Ahmed Alaskar
Journal: Blood (2022)
Endotheliopathy, Innate-Immune Activation and Hemostatic Misbalance Underlying CAR-T Cell Toxicities: Tools for Early and Differential Diagnosis
Authors: Ana Belén Moreno-Castaño, Sara Fernandez, Marta Palomo, Julia Martinez-Sanchez, Alex Ramos, Patricia Molina, Marc Pino, Valentín Ortiz-Maldonado, Julio Delgado, Carlos Fernández De Larrea, Álvaro Urbano-Ispizua, Gines Escolar, Enric Carreras, Francesc Fernández-Avilés, Pedro Castro, Maribel Diaz-Ricart
Journal: Blood (2022)
10-Day Decitabine Versus Intensive Chemotherapy Followed By Transplantation in Fit AML Patients Aged ≥60 Years: Health-Related Quality of Life Outcomes of the Randomized Phase III Trial AML21 of the EORTC Leukemia Group, Gimema, Celg, and Gmds-SG
Authors: Fabio Efficace, Gerwin A. Huls, Michal Kicinski, Walter JFM Van Der Velden, Richard Noppeney, Sylvain Chantepie, Laimonas Griskevicius, Andreas Neubauer, Ernesta Audisio, Mario Luppi, Stephan Fuhrmann, Robin Foà, Martina Crysandt, Gianluca Gaidano, Radovan Vrhovac, Adriano Venditti, Eduardus F.M. Posthuma, Anna Candoni, Frederic Baron, Olivier Legrand, Andrea Mengarelli, Marco Vignetti, Anne Giraut, Corneel Coens, Stefan Suciu, P.W. Wijermans, Michael Luebbert
Journal: Blood (2022)
Regularized Mixture Cure Models Identify a Gene Signature That Improves Risk Stratification within the Favorable-Risk Group in 2017 European Leukemianet (ELN) Classification of Acute Myeloid Leukemia (Alliance 152010)
Authors: Kellie J. Archer, Han Fu, Krzysztof Mrózek, Deedra Nicolet, Jessica Kohlschmidt, Alice S. Mims, Geoffrey L. Uy, Wendy Stock, John C. Byrd, Ann-Kathrin Eisfeld
Journal: Blood (2022)
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression Free Survival on BTK Inhibitor Therapy
Authors: Anfal Alsadhan, Jonathan Chen, Clare Sun, Chingiz Underbayev, Elena Bibikova, Tanja Nicole Hartmann, Maissa Mhibik, Adrian Wiestner
Journal: Blood (2022)
Initial Results of Dose Escalation of ISB 1342, a Novel CD3xCD38 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)
Authors: Sanjay R Mohan, Cristiana Costa Chase, Jesus G Berdeja, Lionel Karlin, Karim Belhadj, Aurore Perrot, Philippe Moreau, Cyrille Touzeau, Thomas Chalopin, Alexander M Lesokhin, Carol Ann Huff, David H. Vesole, Joshua Richter, Jeffrey V. Matous, Igor Proscurshim, Eileen Wolff, Girish Gudi, Andrew Garton, Vinu Menon, Sunitha Gn, Yacine Salhi, Eric J. Feldman, Mohamad Mohty
Journal: Blood (2022)
Germline SAMD9/9L MDS Predisposition Syndromes Are Characterized By Complex Clonal Architecture and Lineage-Specific Escape Mechanisms Including Somatic Genetic Rescue in T and B Lymphocytes
Authors: Charnise Goodings-Harris, Sushree Sangita Sahoo, Sara Lewis, Emilia J. Kozyra, Marc Arribas-Layton, Senthilkumar Ramamoorthy, Rohith Jesudas, Nathan Gray, Miriam Erlacher, Charlotte M. Niemeyer, Marcin W Wlodarski
Journal: Blood (2022)